Cost Of Illness Pengobatan Pasien Cronic Kidney Disease dengan Hemodialisa di Instalasi Rawat Jalan RS Soerojo Magelang
Cost of Illness Treatment for Chronic Kidney Disease Patients with Hemodialysis in the Outpatient Installation of Soerojo Hospital, Magelang
DOI:
https://doi.org/10.30872/jsk.v7i2.1046Keywords:
Analisis Biaya, Biaya Medis, Chronic Kidney DiseaseAbstract
References
[1] M. Nisar et al., “The direct cost of chronic kidney disease (CKD) reported in Asian countries; a systematic literature review,” Cost Effectiveness and Resource Allocation, vol. 22, no. 1, p. 65, Sep. 2024, doi: 10.1186/s12962-024-00566-9.
[2] C. W. G. KDIGO, “KDIGO 2024 Clinical Practice Guideline for the Evaluastion and Management of Chronic Kideney Disease,” Kidney International, vol. 105, no. 4, p. A1, Apr. 2024, doi: 10.1016/S0085-2538(24)00110-8.
[3] N. M. Hustrini, “Chronic Kidney Disease Care in Indonesia: Challenges and Opportunities,” Acta Medica Indonesiana, vol. 55, no. 1, pp. 1–1, Mar. 2023.
[4] S. Sari, Z. Suhada, and T. Triagustini, “Cost of illness pasien gagal ginjal kronis di Rumah Sakit Umum Daerah Arifin Achmad Provinsi Riau,” Jurnal Ilmiah Farmasi, vol. 19, no. 2, pp. 113–125, Dec. 2023, doi: 10.20885/jif.vol19.iss2.art10.
[5] E. Sunariyanti, T. M. Andayani, D. Endarti, and D. A. Puspandari, “Cost Analysis of Chronic Kidney Disease Patients in Indonesia,” Clinicoecon Outcomes Res, vol. 15, pp. 621–629, 2023, doi: 10.2147/CEOR.S388547.
[6] Fauziah, D. Wahyono, and L. E. Budiarti, “Cost Of Illness Dari Chronic Kidney Disease Dengan Tindakan Hemodialisis,” Jurnal Manajemen Dan Pelayanan Farmasi (Journal of Management and Pharmacy Practice), vol. 5, pp. 149–158, 2015.
[7] J. Mende, N. D. Kartikawati, A. Titami, and H. Mahmuda, “Principles Of Dose Adjustment In Patients With Chronic Kidney Failure,” Jurnal Farmasi Sains dan Praktis, pp. 115–126, 2025.
[8] I. Hadning, H. Hendrawan, and W. K. Rahayu, “Cost of illness of chronic kidney disease patients with hemodialysis in Yogyakarta Indonesia,” in AIP Conference Proceedings, AIP Publishing, 2024.
[9] A. R. Villanueva et al., “Cost-of-illness analysis of chronic kidney disease (CKD) management in the Philippines,” Journal of Medical Economics, vol. 28, no. 1, pp. 494–507, Dec. 2025, doi: 10.1080/13696998.2025.2481766.
[10] R. Andhika et al., “One-year Survival of End-Stage Kidney Disease Patients Undergoing Hemodialysis in Indonesia,” Int J Nephrol Renovasc Dis, vol. 18, pp. 87–101, Mar. 2025, doi: 10.2147/IJNRD.S508012.
[11] R. Nindela, S. N. Prastowo, E. F. Zulissetiana, S. Marisdina, and S. S. F. Putri, “Impact of Age Initiation and Duration of Hemodialysis on Impaired Cognitive Function Experienced by Chronic Kidney Disease (CKD) Patients,” Jurnal Profesi Medika : Jurnal Kedokteran dan Kesehatan, vol. 18, no. 1, pp. 36–43, Jun. 2024, doi: 10.33533/jpm.v18i1.7830.
[12] M. Hecking et al., “Sex-Specific Differences in Mortality and Incident Dialysis in the Chronic Kidney Disease Outcomes and Practice Patterns Study,” Kidney Int Rep, vol. 7, no. 3, pp. 410–423, Dec. 2021, doi: 10.1016/j.ekir.2021.11.018.
[13] N. D. Kartikawati, T. M. Andayani, and D. Endarti, “Gambaran dan Luaran Klinik Terapi Anemia Pada Pasien Chronic Kidney Disease Dengan Hemodialisis Di RS PKU Muhammadiyah Yogyakarta,” Majalah Farmaseutik, vol. 19, no. 1, pp. 148–154, 2023.
[14] S. R. Vaidya and N. R. Aeddula, Chronic Renal Failure. StatPearls Publishing, 2020. Accessed: Mar. 18, 2021. [Online]. Available: https://www.ncbi.nlm.nih.gov/books/NBK535404/
[15] D. T. Zainal, D. G. Tamtomo, and B. Murti, “Correlation between the Characteristics of Chronic Kidney Disease Patients Undergoing Hemodialysis and Erythropoietin Stimulating Agent Therapy and Hemoglobin Levels,” Indonesian Journal of Medicine, vol. 9, no. 2, pp. 145-`155, Apr. 2024, doi: 10.26911/theijmed.2024.9.2.715.
[16] H. N. Murdeshwar and F. Anjum, “Hemodialysis,” in StatPearls, Treasure Island (FL): StatPearls Publishing, 2025. Accessed: Sep. 02, 2025. [Online]. Available: http://www.ncbi.nlm.nih.gov/books/NBK563296/
[17] S. Tanaka, T. Nakano, H. Hiyamuta, K. Tsuruya, and T. Kitazono, “Association between Multimorbidity and Kidney Function among Patients with Non-Dialysis-Dependent CKD: The Fukuoka Kidney Disease Registry Study,” J Atheroscler Thromb, vol. 29, no. 8, pp. 1249–1264, Aug. 2022, doi: 10.5551/jat.62900.
[18] C. MacRae, S. W. Mercer, B. Guthrie, and D. Henderson, “Comorbidity in chronic kidney disease: a large cross-sectional study of prevalence in Scottish primary care,” Br J Gen Pract, vol. 71, no. 704, pp. e243–e249, Feb. 2021, doi: 10.3399/bjgp20X714125.
[19] C. Kyriakopoulos and V. Gupta, “Renal Failure Drug Dose Adjustments,” in StatPearls, Treasure Island (FL): StatPearls Publishing, 2023. Accessed: Oct. 28, 2023. [Online]. Available: http://www.ncbi.nlm.nih.gov/books/NBK560512/
[20] X. Liu, P. Chen, Y. Liu, X. Jia, and D. Xu, “Medication burden in patients with dialysis-dependent CKD: a systematic review,” Ren Fail, vol. 46, no. 1, p. 2353341, doi: 10.1080/0886022X.2024.2353341.
[21] H. Jyrkilä et al., “Comorbidity and Medication Trends in Chronic Kidney Disease and Incident Atrial Fibrillation: A Nationwide Cohort Study,” Nephron, vol. 148, no. 11–12, pp. 755–767, Jun. 2024, doi: 10.1159/000539603.
Downloads
Published
Issue
Section
License
Copyright (c) 2026 Jurnal Sains dan Kesehatan

This work is licensed under a Creative Commons Attribution-NonCommercial 4.0 International License.
Deprecated: json_decode(): Passing null to parameter #1 ($json) of type string is deprecated in /home/jskff/public_html/plugins/generic/citations/CitationsPlugin.php on line 68
How to Cite
Similar Articles
- Rio Saddam Pratama, Aditya Fridayanti, Arsyik Ibrahim, Efektivitas Antiinflamasi Fraksi Air Ekstrak Daun Sembukan (Paederia foetida L.) pada Tikus Putih (Rattus norvegicus) , Jurnal Sains dan Kesehatan: Vol. 1 No. 1 (2015): J. Sains Kes.
- Dewi Rahmawati, Jaka Fardaersada, Rani Oktavianir, Hubungan Kepatuhan dan Kualitas Hidup Pasien HIV/AIDS di Kota Samarinda , Jurnal Sains dan Kesehatan: Vol. 2 No. 4 (2020): J. Sains Kes.
- Kony Putriani, Laela Hayu Nurani, Sitarina Widyarini, Pemberian Ko-Kemoterapi Fraksi Etil Asetat Akar Pasak Bumi (Eurycoma longifolia Jack) terhadap Ekspresi Protein NF - K β pada Tikus Sprague Dawley yang Diinduksi DMBA , Jurnal Sains dan Kesehatan: Vol. 1 No. 5 (2016): J. Sains Kes.
- Mukti Priastomo, Riska Putri Patila Sau, Jaka Fadraersada, Observasi Klinik Pemberian Aroma Pandan Wangi Terhadap Tekanan Darah Pasien Hipertensi , Jurnal Sains dan Kesehatan: Vol. 1 No. 10 (2018): J. Sains Kes.
- Rusvirman Muchtar, Yudi Fudiesta, Sukrido, Devi Windaryanti, Analisis Pengaruh Waktu Pemanasan Terhadap Kadar Oksalat Dalam Bayam Hijau (Amarantus hybridus) Dengan Menggunakan Metode Spektrofotometri UV-Vis , Jurnal Sains dan Kesehatan: Vol. 1 No. 8 (2017): J. Sains Kes.
- Tjitjik Srie Tjahjandarie, Alfiah Nur Irza Gunawan, Ratih Dewi Saputri, Mulyadi Tanjung, Senyawa Alkaloid Furokuinolin dari Kulit Batang Zanthoxylum acanthopodium DC , Jurnal Sains dan Kesehatan: Vol. 2 No. 2 (2019): J. Sains Kes.
- Siti Hasanah, Islamudin Ahmad, Laode Rijai, Profil Tabir Surya Ekstrak Dan Fraksi Daun Pidada Merah (Sonneratia caseolaris L.) , Jurnal Sains dan Kesehatan: Vol. 1 No. 4 (2015): J. Sains Kes.
- Amelia Lorensia, Doddy de Queljoe, Yessica Christina Wijaya Tandjung, Profil Kelengkapan Informasi oleh Apoteker tentang Cara Penggunaan Sediaan Handihaler® yang Mengandung Tiotropium Bromida Di Apotek Wilayah Surabaya Timur , Jurnal Sains dan Kesehatan: Vol. 2 No. 1 (2019): J. Sains Kes.
- Suhrah Febrina Karim, Laela Hayu Nurani, Sitarina Widyarini, Pemberian ko-kemoterapi Fraksi Etil AsetatAkar Pasak Bumi (Eurycoma LongifoliaJack) Terhadap Ekspresi Protein Ki-67 pada Tikus Model Kanker Payudarayang diinduksi DMBA , Jurnal Sains dan Kesehatan: Vol. 2 No. 1 (2019): J. Sains Kes.
- Elly Kendali Larasati, Islamudin Ahmad, Arsyik Ibrahim, Efek Antidiare Ekstrak Daun Sembung (Blumea Balsamifera L.) Terhadap Mencit Putih , Jurnal Sains dan Kesehatan: Vol. 1 No. 2 (2015): J. Sains Kes.
You may also start an advanced similarity search for this article.

